Perspective Therapeutics (CATX) Construction in Progress (2011)
Perspective Therapeutics (CATX) reported Construction in Progress of $123613.0 for Q2 2011.
Perspective Therapeutics (CATX) Construction in Progress (2011) Analysis & Trends
Perspective Therapeutics (CATX) has 1 years of Construction in Progress data on file, last reported at $123613.0 in Q2 2011.
- For the quarter ending Q2 2011, Construction in Progress changed N/A year-over-year to $123613.0; the trailing twelve-month figure through Jun 2011 stood at $123613.0 (changed N/A YoY), and the FY2011 full-year result was $123613.0, changed N/A from the prior year.
- Construction in Progress steadied at $123613.0 in Q2 2011.
- In the past five years, Construction in Progress ranged from a high of $123613.0 in Q2 2011 to a low of $123613.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.17 Bn | 175.87 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.06 Bn | 126.18 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.08 Bn | 25.80 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | - |
| 10 | Perspective Therapeutics | 300.97 Mn | 300.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 123,613.00 |